About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Opinion on Drug Metabolism and Toxicology
›
Top Articles
Expert Opinion on Drug Metabolism and Toxicology
Pharmacology
5.5
(top 2%)
Impact Factor
5.8
(top 2%)
extended IF
90
(top 4%)
H-Index
1.4K
authors
1.8K
papers
47.1K
citations
4.5K
citing journals
35.7K
citing authors
Most Cited Articles of Expert Opinion on Drug Metabolism and Toxicology
Title
Year
Citations
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
2006
948
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
2008
508
The Simcyp population-based ADME simulator
2009
375
Caco-2 cell permeability assays to measure drug absorption
2005
306
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
2008
286
The Caco-2 cell monolayer: usefulness and limitations
2008
268
Antisense oligonucleotide pharmacokinetics and metabolism
2009
217
Zebrafish assays for drug toxicity screening
2006
212
Species differences in drug transporters and implications for translating preclinical findings to humans
2013
192
Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges
2008
186
Cytochrome P450 variations in different ethnic populations
2012
179
Minimising the potential for metabolic activation in drug discovery
2005
170
Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
2009
167
ABCG2: structure, function and role in drug response
2008
166
The effect of chronic renal failure on drug metabolism and transport
2008
164
Toxicity of MRI and CT contrast agents
2009
157
The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human
2012
156
Glutathione S-transferases: an overview in cancer research
2010
155
Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies
2006
153
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
2006
152
Role of CAR and PXR in xenobiotic sensing and metabolism
2012
146
Whole-body physiologically based pharmacokinetic models
2007
143
Intestinal efflux transporters and drug absorption
2008
142
In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter
2008
140
The rise of PAMPA
2005
140
previous
2010
2011
2012
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.